Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Scimed

This article was originally published in The Gray Sheet

Executive Summary

Receives approval to market the Maverick, the firm's "first peripheral [percutaneous transluminal angioplasty] catheter designed for large blood vessels," Dale Spencer, Scimed president and CEO, reported at the June 15-17 Piper Jaffray conference in Minneapolis. The firm received 510(k) clearance to market the device on May 20. Scimed says that the catheter is suitable for larger vessels located above the knee, as opposed to the firm's Viper, which is indicated for lower-leg vessels. The firm is waiting to accumulate a more broad product line for peripheral vessels before it adopts a "targeted" marketing approach for the Maverick, which sells for between $100 and $200. Scimed also plans to begin clinical trials later this year for a non-PTCA intravascular therapeutic catheter, Spencer said.

You may also be interested in...



Basilea Stresses Derazantinib's FGFR Kinase Differentiation

Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.

 

ATMPs Put EU Cross-Border Healthcare On The Map

Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.

Start-Up Snapshot: Nanomedic’s Electro-Spinning, Portable Wound Care Device

At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.

UsernamePublicRestriction

Register

MT000792

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel